Primitive stem cells are found in many adult tissues and, throughout life, replenish mature cells lost through attrition or injury. Although thought to be committed to differentiate into cells of their native tissues, some stem cells now appear capable of generating several different cell types, an indication that they have retained considerable plasticity in their genetic programs. The biologic and therapeutic implications of """"""""transdifferentiation"""""""" potential are far reaching but will remain speculative until the concept is better substantiated and the mechanisms that might drive this process are known. Evidence from the applicant's laboratory indicates that adult murine skeletal muscle contains stem cells capable of complete hematopoietic regeneration. Thus, the central hypothesis to be tested is that these stem cells are a subset of myogenic stem cells known to participate in muscle regeneration, they share certain characteristics of bone marrow stem cells, have myogenic activity, are transducible with retroviral vectors, and can be found in human muscle. The major objectives of this proposal are to characterize the biologic properties and markers of muscle-derived hematopoietic stem cells by cell sorting and bone marrow transplantation experiments (Aim 1) so that the cells can be readily identified and purified, and their salient features an be compared with those of marrow-derived stem cells. It will also be important to assess the in vitro and in vivo myogenic potential of purified and clonal populations of muscle-derived hematopoietic stem cells (Aim 2). The results will establish whether or not the stem cells are bipotential precursors of both muscle and blood and therefore an extremely primitive stem cell with a flexible program of differentiation. If the muscle stem cells can be readily transduced with retroviral vectors and the modified cells shown to engraft and stably express a marker gene in transplant recipients (Aim 3), they may afford a novel means of delivering therapeutic genes of interest. Finally, results obtained in mice will need to be verified, both in vivo and in vitro, with stem cells derived from human muscle (Aim 4). Answers from these studies will be crucial in determining if human muscle could provide a source of hematopoietic stem cells for therapeutic exploitation. Successful completion of these aims will not only provide an estimate of the hematopoietic potential of adult muscle-derived stem cells, but also a foundation for future studies into the mechanisms of stem cell transdifferentiation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK058192-01
Application #
6178784
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Badman, David G
Project Start
2000-09-01
Project End
2005-07-31
Budget Start
2000-09-01
Budget End
2001-07-31
Support Year
1
Fiscal Year
2000
Total Cost
$328,900
Indirect Cost
Name
Baylor College of Medicine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Kahle, Juliette J; Souroullas, George P; Yu, Peng et al. (2013) Ataxin1L is a regulator of HSC function highlighting the utility of cross-tissue comparisons for gene discovery. PLoS Genet 9:e1003359
Mayle, Allison; Luo, Min; Jeong, Mira et al. (2013) Flow cytometry analysis of murine hematopoietic stem cells. Cytometry A 83:27-37
Rossi, Lara; Lemoli, Roberto M; Goodell, Margaret A (2013) Gpr171, a putative P2Y-like receptor, negatively regulates myeloid differentiation in murine hematopoietic progenitors. Exp Hematol 41:102-12
Ergen, Aysegul V; Boles, Nathan C; Goodell, Margaret A (2012) Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing. Blood 119:2500-9
Rossi, Lara; Lin, Kuanyin K; Boles, Nathan C et al. (2012) Less is more: unveiling the functional core of hematopoietic stem cells through knockout mice. Cell Stem Cell 11:302-17
Zohren, Fabian; Souroullas, George P; Luo, Min et al. (2012) The transcription factor Lyl-1 regulates lymphoid specification and the maintenance of early T lineage progenitors. Nat Immunol 13:761-9
James, Regis A; Rao, Mitchell M; Chen, Edward S et al. (2012) The Hematopoietic Expression Viewer: expanding mobile apps as a scientific tool. Bioinformatics 28:1941-2
Lukov, Georgi L; Rossi, Lara; Souroullas, George P et al. (2011) The expansion of T-cells and hematopoietic progenitors as a result of overexpression of the lymphoblastic leukemia gene, Lyl1 can support leukemia formation. Leuk Res 35:405-12
Lin, Kuanyin K; Rossi, Lara; Boles, Nathan C et al. (2011) CD81 is essential for the re-entry of hematopoietic stem cells to quiescence following stress-induced proliferation via deactivation of the Akt pathway. PLoS Biol 9:e1001148
Boles, Nathan C; Lin, Kuanyin K; Lukov, Georgi L et al. (2011) CD48 on hematopoietic progenitors regulates stem cells and suppresses tumor formation. Blood 118:80-7

Showing the most recent 10 out of 39 publications